The Drug Development Process
Increasing Efficiency and Cost-Effectiveness
1st Edition
Published on 15. August 1996
Book
Hardback
472 pages
978-0-8247-9727-0 (ISBN)
Description
Containing contributions from the many disciplines involved in a drug's evolution, this timely volume examines the entire pharmaceutical development process, emphasizing approaches to increasing efficiency and reducing costs.
More details
Series
Language
English
Place of publication
New York
United States
Publishing group
Taylor & Francis Inc
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 229 mm
Width: 152 mm
Weight
771 gr
ISBN-13
978-0-8247-9727-0 (9780824797270)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Person
Content
Changing Perspectives in Drug Development
The Evolving Drug Discovery and Development Process, John C. Somberg
Redefining Competition in the Pharmaceutical Industry: A Time for Choice, John Thompson and Jan Gugliotti
Process Challenges in Drug Development
The Impact of Liability and Cost Containment on the Drug Development Process, Martha M. Rumore
Managing the Overall Portfolio for Successful Discover and Development, Rebecca J. Anderson
Pharmaceutical and Formulation Factors
Pharmaceutical Issues in Drug Development, Umesh V. Banakar and Michael C. Makoid
Novel Drug Delivery Systems, Bret Berner and Agis Kydonieus
Drug Design, Pharmacokinetics, and Toxicology
Computer-Aided Drug Design, Terry R. Stouch
New Approaches to Nonclinical Biodisposition Studies, D. Bruce Campbell
Changes in Pharmacokinetics and Drug Metabolism Responsability in Drug Discovery and Development, Peter G. Welling
Chemotherapy
Anticancer Drug Development, Jim Cassidy
Clinical Studies and the Use of Clinical Research Organizations
Clinical Pharmacology in Drug Development: A View to Future Effectiveness, J. Robert Powell, Alan Bye, and Paul D. Rubin
Contracting CROs in Your Organization: New Strategies for New Challenges, Gary D. Lightfoot and John R. Vogel
The Role of Clinical Research Organizations in Drug Development, Albert J. Siemens and James E. Higgins
European and Japanese Approaches
Understanding Drug Development and Registration in Japan, W. J. C. Currie
Increasing the Effectiveness of Clinical Pathology Testing and its Value to Drug Development in Europe, Dai Davies and Karolyn Jackson
New Marketing Authorization Procedures in the European Union and the Impact on Regulatory Strategy, Vaila M. Marshall
The Evolving Drug Discovery and Development Process, John C. Somberg
Redefining Competition in the Pharmaceutical Industry: A Time for Choice, John Thompson and Jan Gugliotti
Process Challenges in Drug Development
The Impact of Liability and Cost Containment on the Drug Development Process, Martha M. Rumore
Managing the Overall Portfolio for Successful Discover and Development, Rebecca J. Anderson
Pharmaceutical and Formulation Factors
Pharmaceutical Issues in Drug Development, Umesh V. Banakar and Michael C. Makoid
Novel Drug Delivery Systems, Bret Berner and Agis Kydonieus
Drug Design, Pharmacokinetics, and Toxicology
Computer-Aided Drug Design, Terry R. Stouch
New Approaches to Nonclinical Biodisposition Studies, D. Bruce Campbell
Changes in Pharmacokinetics and Drug Metabolism Responsability in Drug Discovery and Development, Peter G. Welling
Chemotherapy
Anticancer Drug Development, Jim Cassidy
Clinical Studies and the Use of Clinical Research Organizations
Clinical Pharmacology in Drug Development: A View to Future Effectiveness, J. Robert Powell, Alan Bye, and Paul D. Rubin
Contracting CROs in Your Organization: New Strategies for New Challenges, Gary D. Lightfoot and John R. Vogel
The Role of Clinical Research Organizations in Drug Development, Albert J. Siemens and James E. Higgins
European and Japanese Approaches
Understanding Drug Development and Registration in Japan, W. J. C. Currie
Increasing the Effectiveness of Clinical Pathology Testing and its Value to Drug Development in Europe, Dai Davies and Karolyn Jackson
New Marketing Authorization Procedures in the European Union and the Impact on Regulatory Strategy, Vaila M. Marshall